Teerakanchana's equation transcends over 12 other LDL-C quantification formulae in the North Indian population

Clin Chim Acta. 2022 Jun 1:531:168-176. doi: 10.1016/j.cca.2022.04.006. Epub 2022 Apr 8.

Abstract

Background: Over the last 3 decades, there has been a steady rise in global mortality due to cardiovascular diseases (CVDs). Therefore, timely diagnosis of CVDs is paramount. Low-Density Lipoprotein-cholesterol (LDL-C) in blood serum is one of the biomarkers for the risk assessment of CVDs, measured by direct assays and indirect approaches. The indirect method of LDL-C quantification by Friedewald's formula is more widely used in Indian clinical settings than direct assays due to its time and cost-effectiveness. However, its accuracy has been questioned for a long. We tried to find the formula that work in best agreement with the direct method.

Methods: Lipid profiling was done following a direct homogenous method (LDL-C_M) and LDL-C was calculated by 13 formula. The LDL-C values were categorized into groups based on TG. All the formula were statistically correlated with LDL-C_M.

Results: Teerakanchana's formula has shown a strong positive correlation (r = 0.914) and good agreement M (Lin's CCC = 0.929, CI = 0.918-0.939) with LDL-C_M, followed by Vujovic's formula (r = 0.903, Lin's CCC = 0.925, CI = 0.912-0.936).

Conclusions: Teerakanchana and Vujovic's formula may replace Friedewald to quantify LDL-C in the public health care settings of the North Indian population.

Keywords: Atherosclerosis; Cardiovascular disease; Dyslipidemia; Friedewald; LDL-C; Teerakanchana.

MeSH terms

  • Biomarkers
  • Cardiovascular Diseases* / diagnosis
  • Cholesterol, LDL
  • Humans
  • Triglycerides

Substances

  • Biomarkers
  • Cholesterol, LDL
  • Triglycerides